dc.contributor.author | Hardman, J | |
dc.contributor.author | Liu, Z | |
dc.contributor.author | Brady, G | |
dc.contributor.author | Roe, J | |
dc.contributor.author | Kerawala, C | |
dc.contributor.author | Riva, F | |
dc.contributor.author | Clarke, P | |
dc.contributor.author | Kim, D | |
dc.contributor.author | Bhide, S | |
dc.contributor.author | Nutting, C | |
dc.contributor.author | Harrington, K | |
dc.contributor.author | Paleri, V | |
dc.date.accessioned | 2021-03-24T11:17:20Z | |
dc.date.available | 2021-03-24T11:17:20Z | |
dc.date.issued | 2020-05-01 | |
dc.identifier.citation | Head & neck, 2020, 42 (5), pp. 1089 - 1104 | |
dc.identifier.issn | 1043-3074 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4443 | |
dc.identifier.eissn | 1097-0347 | |
dc.identifier.doi | 10.1002/hed.26100 | |
dc.description.abstract | BACKGROUND: Transoral robotic surgery (TORS) for recurrent head and neck (H&N) cancer is an emerging but relatively infrequent procedure. METHODS: Systematic review and meta-analysis of studies reporting survival data and functional outcomes for patients undergoing TORS for previously treated H&N cancers. RESULTS: Eight hundred seventy-eight records were identified, of which eight were eligible for inclusion, covering 161 cases (range 1-64). The pooled rates were as follows: 2-year overall survival 73.8% (4 studies, range 70.6-75.0, 95% confidence intervals (CI) 65.4 to 81.5, [I2 0.0%, P = 1.0]); 2-year disease-free survival 74.8% (4 studies, range 56.2-92.0, 95% CI 63.3 to 84.8, [I2 36.9%, P = .2]); postoperative hemorrhage 9.3% (4 studies, range 3.3-13.3, 95% CI 4.7 to 15.1, [I2 0.0%, P = .5]). CONCLUSIONS: Functional and oncological outcomes are favorable, although the follow-up is limited in the literature. Larger cohorts with longer follow-up are needed for definitive conclusions to be drawn. | |
dc.format | Print-Electronic | |
dc.format.extent | 1089 - 1104 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | WILEY | |
dc.rights.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
dc.title | Transoral robotic surgery for recurrent cancers of the upper aerodigestive tract-Systematic review and meta-analysis. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2020-01-28 | |
rioxxterms.version | AM | |
rioxxterms.versionofrecord | 10.1002/hed.26100 | |
rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Head & neck | |
pubs.issue | 5 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy | |
pubs.publication-status | Published | |
pubs.volume | 42 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Targeted Therapy | |
icr.researchteam | Targeted Therapy | |
dc.contributor.icrauthor | Hardman, John | |
dc.contributor.icrauthor | Harrington, Kevin | |
dc.contributor.icrauthor | Paleri, Vinidh | |